Live feed
Filing
SC 13G/A
SC 13G/A0000902219-15-000440·TETRAPHASE PHARMACEUTICALS INC
Schedule 13G ownership disclosure
TETRAPHASE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 88165N105
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,634,775
- Percent of class
- 5.3300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-15-000440
- Form type
- SC 13G/A
- Filer
- TETRAPHASE PHARMACEUTICALS INC
- CIK
- CIK 1373707
- Filed
- Feb 12, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership